Fintech PR
UnionPay’s Innovative Payment Products Showcased at the CIIE for Convenient Cross-Border Payment Services
SHANGHAI, Nov. 14, 2023 /PRNewswire/ — On the site of the sixth China International Import Expo (CIIE) at the National Convention and Exhibition Center (Shanghai), the commercial card solution brought by UnionPay International (UPI) catches the eyes of several exhibitors from Central Asia. “This product helps businesses manage the travel expenses of their employees and is tailored for the payment demand of professionals in cross-border trade. We have received several client queries these days,” explains a UPI staff member.
UPI has stepped up efforts to enhance its capabilities to facilitate payments made by visitors to China. Outside China’s mainland, over 200 million UnionPay cards have been issued and 180 UnionPay-standard wallets launched, providing exhibitors with more convenient payment options. A variety of signature products have also appeared at the CIIE such as commercial cards, integrated B2B solutions and the Shop the World platform, which meet the diverse payment needs in cross-border trade. Together with Bank of China (BOC), the official strategic partner of the event, UPI has rolled out a wealth of offers, cash rebates and exclusive privileges.
Diversified Payment Options in China for International Exhibitors
At the booth of Serbia, one of the guest countries of honor at the Country Exhibition, 24 businesses have made a collective appearance, a record number of Serbian exhibitors at the event as media reports suggest. In line with the deepening economic and trade cooperation between China and Serbia, the Balkan country’s national payment system DinaCard issued UnionPay cards for the first time in 2022, drawing a large number of card applications from Serbian residents, and over 400,000 cards have been delivered in slightly more than a year.
The card issuance project in Serbia is a snapshot of UPI’s efforts to accelerate business localization and enhance the cross-border payment experience for people outside China’s mainland, especially when they visit China. To that end, UPI has actively contributed to the improvement of the payment service system for visitors to China, which involves card payments for large-amount transactions, QR payments for small-ticket purchases and cash payments as a backup method. Currently, UnionPay cards have been issued in 78 countries and regions outside China’s mainland, and over 170 million cards have been issued in the participating countries and regions of the Belt and Road Initiative. One out of every four new cards issued in the Asia-Pacific region carries the UnionPay brand. At the CIIE, UPI has signed a large-scale card issuance agreement with an Australian financial institution. These cards can be used on a cross-border basis and are accepted by 25 million merchants and on 880,000 ATMs in China’s mainland. In Shanghai, for instance, the cards can transact on POS terminals at merchant locations frequented by international visitors such as commercial zones, cultural and tourism sites, airports, and railway stations. Key merchants cover transport hubs including the Hongqiao International Airport, Pudong International Airport, Hongqiao Railway Station, and Shanghai Railway Station.
With the changes of consumers’ payment habits, UnionPay-powered wallets have increasingly become the preferred payment method for a growing number of international exhibitors to pay in China’s mainland. In recent years, UPI has ramped up digital wallet collaboration with international card issuers and payment companies. This allows apps outside the Chinese mainland to make QR payments to global UnionPay QR merchants, including those in the mainland, by linking local UnionPay cards or issuing UnionPay virtual cards. More than a hundred of such wallets have been rolled out in 35 countries and regions outside China’s mainland, including well-known applications such as Malaysia’s GoPayz, K PLUS by Thailand’s Kasikornbank and South Korea’s NaverPay. Users of these wallets can make seamless QR payments in China’s mainland without additional apps.
Abundant Benefits and Offers for Spending in China
UPI signed a Memorandum of Co-operation to Support the Sixth China International Import Expo with the Shanghai Branch of BOC, the official strategic partner of the CIIE. The Chinese lender has issued millions of UnionPay cards outside China’s mainland. Its banking apps in markets such as Hong Kong and Macao SARs, Japan, Southeast Asia, and Australia all support UnionPay QR payment. These products have become familiar cross-border payment tools for exhibitors coming to the mainland. During the CIIE, exhibitors can enjoy exclusive cash rebates when using UnionPay credit cards issued by BOC (Hong Kong), BOC Macau Branch and BOC Singapore Branch, and holders of the BOC Greater Bay Area Youth Card can enjoy an extra cash rebate up to 6%.
UnionPay also provides multiple benefits and offers to international exhibitors. Visa centers in cities such as Sydney and Melbourne of Australia, Jakarta of Indonesia, Tokyo of Japan and Seoul of South Korea have launched fast-track visa services for UnionPay cardholders. Particularly, international cardholders using UnionPay cards or UnionPay standard wallets can enjoy CNY 30 off for spending of CNY 200 or more at New World City Plaza, Jiu Guang Department Store, Bicester Village Shanghai and other malls in well-known shopping districts. The Oriental Pearl Tower, Lianhua Supermarket, McDonald’s and other merchants in the culture, tourism, grocery, and F&B sectors have also announced CNY 20 off for every purchase over CNY 50 exclusively for these cardholders.
Innovative Products for Cross-Border Trade
While enhancing the inbound payment experience of overseas exhibitors, UPI has also launched innovative payment products and solutions in line with its strengths in network, product and service to meet the diversified payment needs in cross-border trade. Such offering has attracted the attention of cross-border e-commerce retailers, import and export businesses and multinational corporations in and outside China’s mainland.
Since the opening of the CIIE, UPI’s integrated B2B solution has invited many queries from exhibitors with its “end-to-end” features. Various product offerings such as cross-border e-commerce solutions, digital card issuing schemes for commercial card, and innovative payment solutions for overseas enterprises can meet the cross-border payment needs of businesses and facilitate the digital transformation of trade. Among them, UnionPay commercial products, including business card, corporate card and purchase card, have reached million-level issuance in over ten countries and regions such as Southeast Asia, Europe and Africa.
The Shop the World platform developed by UPI empowers international merchants as they tap into the Chinese market. A Southeast-Asian seller expressed the interest to access the platform on the spot, “UnionPay’s Shop the World is a good channel. The UnionPay card has a wide customer base in China, and through this platform, we can bring our products to more Chinese consumers.” In addition, in order to reduce the operating costs of non-Chinese merchants, UPI offers storefront management services alongside diverse marketing tools to help merchants attract more customers.
View original content:https://www.prnewswire.co.uk/news-releases/unionpays-innovative-payment-products-showcased-at-the-ciie-for-convenient-cross-border-payment-services-301986841.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News5 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News4 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News7 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News4 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system
-
Latest News4 days ago
Report Finds that Huawei DigiTruck Training Helps Boost Income, Employment and Entrepreneurship
-
Latest News7 days ago
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
-
Latest News4 days ago
Zilch Partners with Amazon Web Services to Drive AI Innovation